Therapeutic Resistance Group Exercise Training for Head & Neck Cancer Survivors
TARGET
Evaluating Outcomes From a Combined Supervised Therapeutic and Physical Exercise Program for Post-surgical Head and Neck Cancer Survivors: A Randomized Controlled Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
The investigators will conduct a randomized controlled trial examining 12-week, 24-week and one year outcomes from a combined therapeutic and physical exercise program that aims to bridge head-and-neck cancer survivors from acute care rehabilitation services to community-based exercise programming.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 28, 2015
CompletedFirst Posted
Study publicly available on registry
January 6, 2016
CompletedStudy Start
First participant enrolled
March 31, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2020
CompletedJanuary 3, 2024
December 1, 2023
4 years
December 28, 2015
December 31, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Functional Assessment of Cancer Therapy: Fatigue Scale Questionnaire
Cancer related fatigue
change from baseline to 12 weeks.
Secondary Outcomes (13)
Shoulder range of motion in degrees.
Change from baseline to one year
Body mass index
Change from baseline to 24 weeks.
1 repetition maximum (1RM) strength for seated row in pounds.
Change from baseline to 12 weeks.
Neck Range of Motion in degrees.
Change from baseline to 12 weeks.
Upper extremity muscular endurance: number of repetitions performed.
baseline, 12-weeks, 24-weeks, one year
- +8 more secondary outcomes
Other Outcomes (4)
Physical activity level in minutes per week (average over the previous one month period).
Change in monthly average physical activity from baseline to one year.
Cost of programming
one year
Exercise Adherence
Change from baseline to 1 year.
- +1 more other outcomes
Study Arms (2)
Therapeutic Exercise
ACTIVE COMPARATORTherapeutic Exercise Program (standard care) will include: 1. Neck range of motion and strengthening, and posture retraining. 2. Shoulder specific progressive resistance exercise program that focuses on spinal accessory nerve dysfunction and rehabilitation of trapezius muscle function.
Therapeutic + Lower Body Exercise
EXPERIMENTALThe Therapeutic Exercise Program (standard care) will include: 1. Neck range of motion and strengthening, and posture retraining. 2. Shoulder specific progressive resistance exercise program that focuses on spinal accessory nerve dysfunction and rehabilitation of trapezius muscle function. The Resistance Exercise component will target 6-8 muscle groups of the lower extremities and core including gluteal, quadriceps, hamstrings, abdominals, and gastrocnemius muscles. A progressive introduction of exercises will occur over the first 3 weeks. 1. a personalized program of lower extremity resistance exercises 2. core strengthening exercises
Interventions
A specialized therapeutic exercise program to address neck and shoulder dysfunction due to spinal accessory nerve damage.
A combined therapeutic exercise program (as per the comparison arm) plus the addition of lower body resistance exercise
Eligibility Criteria
You may qualify if:
- Squamous cell carcinoma/ thyroid cancer/ melanoma or lymphoma involving: oral cavity, oropharynx, larynx or hypopharynx, or lymph nodes in the neck region
- Surgical treatment includes radical neck dissection, modified radical neck dissection and other variants of functional/selective neck dissection OR radiation therapy to lymph node regions
- Presenting with shoulder and/ or neck dysfunction related to cancer treatment
- Karnofsky Performance Status greater than or equal to 60%
- No evidence of residual cancer in the neck and no distant (M0) metastasis. Potential participants with symptoms suggestive of distant metastasis (M1) must have appropriate investigations (e.g. bone scan) to rule these out.
- Participants must have completed their head and neck/ thyroid/ melanoma/ lymphoma cancer treatment (minimum 4 weeks post treatment)
- Pre-participation Screening: Prior to participation in the exercise program, potential participants will complete general and cancer-specific Physical Activity Readiness Questionnaires (PAR-Q+) to determine appropriateness for the exercise program. Physician consent and approval for supervised exercise will be required prior to enrollment.
You may not qualify if:
- A participant will be ineligible if they present with medical illness or psychiatric illness, which, in the opinion of the investigators, would impact his/her ability to participate in exercise or interfere with follow-up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Albertalead
- Cross Cancer Institutecollaborator
Study Sites (1)
University of Alberta/ Cross Cancer Institute
Edmonton, Alberta, T6G 2G4, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Margaret L. McNeely, PhD
University of Alberta
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 28, 2015
First Posted
January 6, 2016
Study Start
March 31, 2016
Primary Completion
March 15, 2020
Study Completion
March 30, 2020
Last Updated
January 3, 2024
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share